New drug tested to boost red blood cells in diabetic kidney patients
NCT ID NCT07359027
Summary
This study tested whether the drug Roxadustat could safely and effectively treat anemia (low red blood cells) in adults with moderate diabetic kidney disease. For 24 weeks, 124 participants took the drug while researchers monitored their blood counts, iron levels, and overall health. The goal was to see if this oral medication could be a good option for managing this common complication without needing frequent injections.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Second Xiangya Hospital, Central South University
Changsha, 410000, China
Conditions
Explore the condition pages connected to this study.